Ym1蛋白质晶体促进了2型免疫
Ines Heyndrickx1,2, Kim Deswarte1,2, Kenneth Verstraete3,4
1Laboratory of Immunoregulation and Mucosal Immunology, VIB-UGent Center for Inflammation Research, Ghent, Belgium.
由Ym1/Ym2蛋白质制成的Charcot-Leyden (CLCs) 的类伪晶体刺激了先天性和适应性免疫力. 这些蛋白质晶体作为2型免疫辅助剂,增强了eosinophilic炎症.
科学领域:
- 免疫学 免疫学 免疫学
- 晶体学 晶体学是指结晶学.
- 蛋白质科学 蛋白质科学
背景情况:
- 自发的蛋白质结晶是罕见的,但在富含乙氨基酸的炎症中观察到.
- 人类的Charcot-Leyden晶体 (CLCs) 由加勒-10 (Gal10) 组成.
- 小鼠从基因酶样蛋白Ym1和Ym2中形成伪CLC.
研究的目的:
- 为了研究伪CLCs的生物效应.
- 在体内了解Ym1和Ym2蛋白质晶体的功能.
- 为了探索它们在氨酸性炎症中的作用.
主要方法:
- 生产复合的Ym1蛋白质晶体.
- 用X射线晶体学来确定晶体结构和包装.
- 将晶体和可溶性Ym1注入小鼠呼吸道.
- 评估先天性和适应性免疫反应,包括树突细胞 (DC) 激活.
主要成果:
- 再组合的Ym1晶体具有与原生小鼠晶体相同的结构和包装.
- 晶体Ym1,但不溶解的Ym1,可以刺激先天性和适应性免疫力.
- Ym1晶体作为一种2型免疫辅助剂,促进了eosinophilic炎症.
- 树突细胞 (DCs) 是由Ym1晶体触发的.
结论:
- 鼠Ym1蛋白质晶体在异酸性炎症部位加强2型免疫力.
- 伪CLC可以作为研究人类CLC生物学的一个有价值的模型.
- Ym1晶体调节免疫反应,突出显示了它们的生物学意义.
更多相关视频
07:07Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice
Published on: June 27, 2020
08:22Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
Published on: May 31, 2020
相关概念视频
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Cell-mediated Immune Responses
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
